The global infectious disease rapid diagnostic testing market size is expected to reach USD 51.01 Billion in 2030 and register a revenue CAGR of 7.0% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of infectious diseases and emergence of COVID-19 are some key factors driving market revenue growth.